Theranexus is an innovative biopharmaceutical company that spun off from the French Alternative Energies and Atomic Energy Commission (CEA). It specializes in the treatment of rare central nervous system disorders and is a pioneer in the development of drug candidates targeting both neurons and glial cells. Theranexus has a unique advanced therapy candidate identification and characterization platform focused on rare neurological disorders and an initial drug candidate in clinical development for Batten disease.
Looking for a particular Theranexus employee's phone or email?
Theranexus Questions
The Theranexus annual revenue was $5 million in 2026.
Mathieu Charvériat is the CEO and Chairman of Theranexus.
11 people are employed at Theranexus.
Theranexus is based in Lyon, Auvergne-Rhône-Alpes.
The NAICS codes for Theranexus are [325, 32541, 32, 3254].
The SIC codes for Theranexus are [28, 283].
Top Theranexus Employees
-
32
-
Anaelle da Costa
In vitro R and D engineer at Theranexus
Fontenay-aux-Roses, FR2
Related Companies
